PMRT for patients With T1-2 tumors with one to three positive axillary lymph nodes who undergo ALND
PMRT for patients with T1-2 tumors and a positive SNB who do not undergo completion ALND
PMRT for patients with clinical stage I or II cancers who have received NAST
Should RNI include both the IMNs and supraclavicular-axillary apical nodes when PMRT is used in patients with T1-2 tumors with one to three positive axillary nodes?
December 1, 2016
External Publication Status
Country of Publication
A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a focused update of the American Society of Clinical Oncology guideline concerning use of postmastectomy radiotherapy (PMRT).
Target Patient Population
Post mastectomy patients
Female, Adolescent, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room, Outpatient, Radiology services
Nurse, nurse practitioner, physician, physician assistant
D001943 - Breast Neoplasms, D018787 - Radiation Oncology, D011827 - Radiation, D008408 - Mastectomy
breast cancer, radiation therapy, Adjuvant Radiation Therapy, Breast Cancer